Login / Signup

The evaluation of the utility of the GENECUBE HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol.

Asami NaitoYoshihiko KiyasuYusaku AkashiAkio SugiyamaMasashi MichibuchiYuto TakeuchiShigeyuki NotakeKoji NakamuraHiroichi IshikawaHiromichi Suzuki
Published in: PloS one (2021)
GENECUBE® HQ SARS-CoV-2 provided high analytical performance for the detection of SARS-CoV-2 in anterior nasal samples and saliva samples.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • randomized controlled trial
  • chronic rhinosinusitis
  • coronavirus disease